Trial
NCT02921737
TAS-102 (Lonsurf) in Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma Post First Line Chemotherapy (UF-STO-PANC-003)
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Florida
Collaborators
Taiho Oncology, Inc.
Condition
Pancreatic Cancer
Intervention
TAS-102
Why stopped
insufficient time to accrue sufficient subjects before end of funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-02-04